LONDON - Advanced trials of a new mosquito medicine that began in Africa last week could lead to the world's first malaria vaccine becoming available as soon as 2011, a newspaper reported on Monday.
GlaxoSmithKline (GSK) began Phase-III trials of its Mosquirix medicine on Wednesday as scientists began injecting 1,200 infants and children in the town of Bagamoyo in Tanzania.
Eventually, up to 16,000 patients will be immunised in seven African countries, including Mozambique, Kenya and Malawi. .
Click here to read the entire story.
Latest from Pest Control Technology
- Earn CEUs from Your State at Next Week’s Mosquito Control Virtual Conference
- Preserving Culture, Providing Opportunities Key in Hoffman’s Decision
- Winter Weather Could Decide How Bad Mosquito Season Gets
- Trent Frazer Discusses How Mosquitoes Survive Winter
- Barnes Exterminating Acquires Tennessee Pest Solutions
- Pest Index Up 9% YOY in January
- Arrow Exterminators Acquires Hoffman's Exterminating
- PMPs Plan Mera Peak Summit for Parkinson's
